Riskpilot← Back to searchSign inGet full accessSchultz läkarpraktik AB
ABActiveOrg 5567638902Svartkärrsvägen 20General medical practice activities · NACE 8621Est. 20082 employees
Revenue 2025
SEK 212K
-83% vs 2024
EBITDA margin
-227.8%
-374% vs 2024
Equity ratio
90.0%
Financial strength
Net profit 2025
SEK 75K
-40% vs 2024
| Revenue | SEK 212K | -83% |
| EBITDA | SEK -483K | -374% |
| Net profit | SEK 75K | -40% |
| Total assets | SEK 4,2M | -15% |
| Equity | SEK 3,8M | -3% |
| Employees | 2 | — |
Legal name
Schultz läkarpraktik AB
Org number
5567638902
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
22 augusti 2008
Share capital
SEK 100 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Föremålet för bolagets verksamhet ska vara att bedriva medicinsk behandling, medicinsk konsultverksamhet, försäljning av medicinska artiklar samt därmed förenlig verksamhet.
Address
Svartkärrsvägen 20
Phone
+46762460626
Email
ezen@live.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 2 861 | 2 891 | 2 903 | 1 260 | 212 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 1 793 | 1 478 | 1 858 | −102 | −483 |
| Depreciation & amort. | −26 | −26 | −26 | −26 | −0 |
| EBIT | 1 767 | 1 452 | 1 832 | −128 | −483 |
| Net financials | — | — | — | 1 | −2 |
| Profit before tax | 1 434 | 1 139 | 2 278 | 171 | 102 |
| Tax | −297 | −237 | −481 | −46 | −27 |
| Net profit | 1 137 | 902 | 1 797 | 125 | 75 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 3 962 | 5 192 | 5 533 | 4 984 | 4 234 |
| Equity | 2 430 | 3 332 | 4 029 | 3 943 | 3 809 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 129 | 145 | 235 | 70 | 41 |
| Total debt | 129 | 145 | 235 | 70 | 41 |
EBITDA margin
-227.8%
This company
15.8%
Market median
-1542% vs market
20212025
Equity ratio
90.0%
This company
38.2%
Market median
+136% vs market
20212025
Return on equity
2.0%
This company
18.4%
Market median
-89% vs market
20212025
Net profit margin
35.4%
This company
8.1%
Market median
+337% vs market
20212025
Asset turnover
0.05×
This company
1.12×
Market median
-96% vs market
20212025
Debt / equity
0.11×
This company
0.62×
Market median
+82% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
| Chairman | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Schultz läkarpraktik AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Elvira Schultz | Board of Directors | 0 companies |
| Olof Eggert Einarsson | Deputy Board Member | 0 companies |
| Karina Schultz | Board of Directors | 0 companies |
| Eva Zemfira Einarsson | Chairman | 0 companies |